Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling

被引:38
作者
Cecchi, Fabiola [1 ]
Pajalunga, Deborah [2 ,3 ]
Fowler, C. Andrew [2 ]
Ueren, Aykut [4 ]
Rabe, Daniel C. [1 ]
Peruzzi, Benedetta [1 ]
MacDonald, Nicholas J. [3 ]
Blackman, Davida K. [3 ]
Stahl, Stephen J. [5 ]
Byrd, R. Andrew [2 ]
Bottaro, Donald P. [1 ]
机构
[1] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA
[2] Frederick Natl Lab Canc Res, Macromol NMR Sect, Struct Biophys Lab, Frederick, MD 21702 USA
[3] EntreMed Inc, Rockville, MD 20850 USA
[4] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA
[5] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA
关键词
CRYSTAL-STRUCTURE; FACTOR/SCATTER FACTOR; FACTOR ISOFORMS; NK1; FRAGMENT; C-MET; FUNCTIONAL-CHARACTERIZATION; PROVIDE INSIGHTS; STRUCTURAL BASIS; DOMAIN RECEPTOR; FACTOR REVEALS;
D O I
10.1016/j.ccr.2012.06.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocyte growth factor (HGF) and vascular endothelial cell growth factor (VEGF) regulate normal development and homeostasis and drive disease progression in many forms of cancer. Both proteins signal by binding to receptor tyrosine kinases and heparan sulfate (HS) proteoglycans on target cell surfaces. Basic residues comprising the primary HS binding sites on HGF and VEGF provide similar surface charge distributions without underlying structural similarity. Combining three acidic amino acid substitutions in these sites in the HGF isoform NK1 or the VEGF isoform VEGF165 transformed each into potent, selective competitive antagonists of their respective normal and oncogenic signaling pathways. Our findings illustrate the importance of HS in growth factor driven cancer progression and reveal an efficient strategy for therapeutic antagonist development.
引用
收藏
页码:250 / 262
页数:13
相关论文
共 50 条
[1]   Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding [J].
Appleton, Brent A. ;
Wu, Ping ;
Maloney, Janice ;
Yin, Jian Ping ;
Liang, Wei-Ching ;
Stawicki, Scott ;
Mortara, Kyle ;
Bowman, Krista K. ;
Elliott, J. Michael ;
Desmarais, William ;
Bazan, J. Fernando ;
Bagri, Anil ;
Tessier-Lavigne, Marc ;
Koch, Alexander W. ;
Wu, Yan ;
Watts, Ryan J. ;
Wiesmann, Christian .
EMBO JOURNAL, 2007, 26 (23) :4902-4912
[2]   Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature [J].
Backer, MV ;
Gaynutdinov, TI ;
Patel, V ;
Bandyopadhyaya, AK ;
Thirumamagal, BTS ;
Tjarks, W ;
Barth, RF ;
Claffey, K ;
Backer, JM .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (09) :1423-1429
[3]   Opinion -: Invasive growth:: a MET-driven genetic programme for cancer and stem cells [J].
Boccaccio, Carla ;
Comoglio, Paolo M. .
NATURE REVIEWS CANCER, 2006, 6 (08) :637-645
[4]   Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [J].
Carmeliet, P ;
Ng, YS ;
Nuyens, D ;
Theilmeier, G ;
Brusselmans, K ;
Cornelissen, I ;
Ehler, E ;
Kakkar, VV ;
Stalmans, I ;
Mattot, V ;
Perriard, JC ;
Dewerchin, M ;
Flameng, W ;
Nagy, A ;
Lupu, F ;
Moons, L ;
Collen, D ;
D'Amore, PA ;
Shima, DT .
NATURE MEDICINE, 1999, 5 (05) :495-502
[5]   Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors [J].
Castagnino, P ;
Lorenzi, MV ;
Yeh, J ;
Breckenridge, D ;
Sakata, H ;
Munz, B ;
Werner, S ;
Bottaro, DP .
ONCOGENE, 2000, 19 (05) :640-648
[6]   Targeting the HGF/Met signalling pathway in cancer [J].
Cecchi, Fabiola ;
Rabe, Daniel C. ;
Bottaro, Donald P. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (07) :1260-1270
[7]  
Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72
[8]   The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 [J].
Christinger, HW ;
Fuh, G ;
de Vos, AM ;
Wiesmann, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10382-10388
[9]   Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor [J].
Dougher, AM ;
Wasserstrom, H ;
Torley, L ;
Shridaran, L ;
Westdock, P ;
Hileman, RE ;
Fromm, JR ;
Anderberg, R ;
Lyman, S ;
Linhardt, RJ ;
Kaplan, J ;
Terman, BI .
GROWTH FACTORS, 1997, 14 (04) :257-268
[10]   Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration [J].
Favier, Benoit ;
Alam, Antoine ;
Barron, Pauline ;
Bonnin, Jacques ;
Laboudie, Patricia ;
Fons, Pierre ;
Mandron, Marie ;
Herault, Jean-Pascal ;
Neufeld, Gera ;
Savi, Pierre ;
Herbert, Jean-Marc ;
Bono, Francoise .
BLOOD, 2006, 108 (04) :1243-1250